Corynebacterium falsenii bacteremia occurring in an infant on vancomycin therapy.
Corynebacterium falsenii was described in 1998 as a new Corynebacterium species. We give the first detailed description of a clinically significant Corynebacterium falsenii bacteremia occurring in an infant while on vancomycin therapy.
Iroh Tam
Pui-Ying
PY
Department of Pediatric Infectious Diseases, Maxwell Finland Laboratory for Infectious Diseases, 670 Albany St., 6/F, Boston, MA 02118, USA. pui-ying.irohtam@bmc.org
Fisher
Mark A
MA
Miller
Nancy S
NS
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D016470:Bacteremia / Q000175:diagnosis* / Q000382:microbiology; D016000:Cluster Analysis; D003352:Corynebacterium / Q000302:isolation & purification*; D003354:Corynebacterium Infections / Q000175:diagnosis* / Q000382:microbiology; D004269:DNA, Bacterial / Q000737:chemistry / Q000235:genetics; D004275:DNA, Ribosomal / Q000737:chemistry / Q000235:genetics; D006801:Humans; D007223:Infant; D008297:Male; D008826:Microbial Sensitivity Tests; D010802:Phylogeny; D012336:RNA, Ribosomal, 16S / Q000235:genetics; D017422:Sequence Analysis, DNA; D014640:Vancomycin / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D004269:DNA, Bacterial; D004275:DNA, Ribosomal; D012336:RNA, Ribosomal, 16S; D014640:Vancomycin